Repository logo
 

Cortical gene expression architecture links healthy neurodevelopment to the imaging, transcriptomics and genetics of autism and schizophrenia

Published version
Peer-reviewed

Repository DOI


Type

Article

Change log

Authors

Wagstyl, Konrad 
Arnatkeviciute, Aurina 

Abstract

Human brain organisation involves the coordinated expression of thousands of genes. For example, the first principal component (C1) of cortical transcription identifies a hierarchy from sensorimotor to association regions. Here, optimised processing of the Allen Human Brain Atlas revealed two new components of cortical gene expression architecture, C2 and C3, which are distinctively enriched for neuronal, metabolic and immune processes, specific cell-types and cytoarchitecture, and genetic variants associated with intelligence. Using additional datasets (PsychENCODE, Allen Cell Atlas, and BrainSpan), we found that C1-C3 represent generalisable transcriptional programmes that are coordinated within cells, and differentially phased during foetal and postnatal development. Autism spectrum disorder and schizophrenia were specifically associated with C1/C2 and C3, respectively, across neuroimaging, differential expression, and genome-wide association studies. Evidence converged especially in support of C3 as a normative transcriptional programme for adolescent brain development, which can lead to atypical supra-granular cortical connectivity in people at high genetic risk for schizophrenia.

Description

Keywords

Humans, Schizophrenia, Transcriptome, Cerebral Cortex, Female, Male, Autism Spectrum Disorder, Adolescent, Autistic Disorder, Genome-Wide Association Study, Child, Adult, Neuroimaging

Journal Title

Nature Neuroscience

Conference Name

Journal ISSN

1097-6256
1546-1726

Volume Title

Publisher

Nature Research
Sponsorship
Medical Research Council (MR/M009041/1)
MQ: Transforming Mental Health (MQ17-24 Vertes)
National Institute for Health and Care Research (IS-BRC-1215-20014)
R.D. was supported by the Gates Cambridge Trust (OPP1144). J.S. was supported by NIMH T32MH019112-29 and K08MH120564. A.A. was funded by a grant from the Australian Research Council (ARC) under its Linkage Project scheme (LP160101592). R.A.I.B. was supported by the Autism Research Trust. K.S.W. was supported by the Wellcome Trust (215901/Z/19/Z). E.T.B. was supported by an NIHR Senior Investigator award and the Wellcome Trust collaborative award for the Neuroscience in Psychiatry Network (NSPN). A.R. was supported by the National Institute of Mental Health Intramural Research Program (NIH Annual Report Number, 1ZIAMH002949-04). P.E.V. is a Fellow of MQ: Transforming Mental Health (MQF17_24).

Version History

Now showing 1 - 2 of 2
VersionDateSummary
2*
2024-05-08 15:03:14
Published version added
2024-01-23 00:30:51
* Selected version